Assessment of Efficacy and Safety of SPN-810 for the Treatment of Impulsive Aggression (IA) in Adolescent Subjects with Attention Deficit/Hyperactivity Disorder (ADHD) in Conjunction with Standard ADHD Treatment

  • STATUS
    Recruiting
Updated on 23 November 2020

Summary

Efficacy and safety of SPN-810 treatment in reducing the frequency of impulsive aggression (IA) behaviors in adolescents with ADHD when taken in conjunction with standard ADHD treatment.

 

Description

Details
Condition Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
Clinical Study IdentifierTX229383
Last Modified on23 November 2020

Eligibility

Yes No Not Sure

Inclusion Criteria

Healthy male or female subjects, age 12-17 years at the time of screening, including outpatients in foster care living at home
Medically healthy with clinically normal laboratory profiles, vital signs and electrocardiograms (ECGs)
Able and willing to swallow tablets whole and not chewed, cut or crushed
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note